Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Showing news for:SENORES
Clear all filters
negative
CNBC TV18 - Markets 58d ago
Senores Pharma Q4 Results: Stock drops 5% on sequential earnings weakness
Senores Pharmaceuticals shares fell over 5% despite strong year-on-year earnings growth, as investors reacted to sequential weakness in EBITDA and margins amid a softer operational performance in the March quarter.
MOGSECSENORESFinancial ServicesHealthcare
positive
Moneycontrol NaNd ago
Buy Senores Pharma; target of Rs 1640: Choice Institutional Equities
Choice Institutional Equities is bullish on Senores Pharma has recommended buy rating on the stock with a target price of Rs 1640 in its research report dated July 08, 2026.
CHOICEINSENORESSPARCFinancial ServicesHealthcare